Showing results (31-40 of 75) with videos related to

Sort By:
Pageof 8
Bone Marrow Transplantation|February 26, 2025
Long-term patient-reported outcomes following allogeneic hematopoietic cell transplantationSina Alexandra Beer, Johanna Blättel, Kristina Reuß, et al.
BMC Infectious Diseases|December 11, 2014
Clinical and treatment-related risk factors for nosocomial colonisation with extensively drug-resistant Pseudomonas aeruginosa in a haematological patient population: a matched case control studyMatthias Willmann, Anna M Klimek, Wichard Vogel, et al.
Cytotherapy|September 3, 2013
Depletion of T-cell receptor alpha/beta and CD19 positive cells from apheresis products with the CliniMACS deviceMichael Schumm, Peter Lang, Wolfgang Bethge, et al.
Arthritis Research & Therapy|March 21, 2024
Patients with systemic sclerosis and low CD4 numbers after autologous stem cell transplantation have a favorable outcomeAnn-Christin Pecher, Reinhild Klein, Ina Koetter, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|June 3, 2024
Adenovirus- and cytomegalovirus-specific adoptive T-cell therapy in the context of hematologic cell transplant or HIV infection - A single-center experienceBenedikt Obermaier, Christiane Braun, Luca Hensen, et al.
Leukemia & Lymphoma|April 7, 2016
EBV-negative aggressive B-cell lymphomas of donor origin after allogeneic hematopoietic stem cell transplantation: a report of three casesBirgit Federmann, Irina Bonzheim, Jens Schittenhelm, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 5, 2013
Dynamics of coexisting HCMV-UL97 and UL54 drug-resistance associated mutations in patients after haematopoietic cell transplantationKatharina Göhring, Dana Wolf, Wolfgang Bethge, et al.
Academic Radiology|February 14, 2012
Assessment of splenic perfusion in patients with malignant hematologic diseases and spleen involvement, liver cirrhosis and controls using volume perfusion CT (VPCT): a pilot studyAlexander W Sauter, Stefan Feldmann, Daniel Spira, et al.
Annals of Hematology|September 29, 2015
Reduced-intensity conditioning with fludarabine and busulfan for allogeneic hematopoietic cell transplantation in elderly or infirm patients with advanced myeloid malignanciesDominik Schneidawind, Birgit Federmann, Corina Buechele, et al.
Oncotarget|March 17, 2018
Dasatinib overrides the differentiation blockage in a patient with mutant-KIT D816V positive CBFβ-MYH11 leukemiaKerstin M Kampa-Schittenhelm, Wichard Vogel, Irina Bonzheim, et al.
Pageof 8